 |
|
Neonatal Abstinence Syndrome After In Utero Exposure to Selective Serotonin Reuptake Inhibitors in Term Infants
Rachel Levinson-Castiel, MD;
Paul Merlob, MD;
Nehama Linder, MD;
Lea Sirota, MD;
Gil Klinger, MD
Arch Pediatr Adolesc Med. 2006;160:173-176.
Objective To compare the prevalence and clinical characteristics of neonatal abstinence syndrome in neonates exposed and not exposed to selective serotonin reuptake inhibitors (SSRIs) in utero.
Design Cohort study.
Setting Tertiary care center.
Patients One hundred twenty term infants, of whom 60 had prolonged in utero exposure to SSRIs, including paroxetine hydrochloride, fluoxetine, citalopram hydrobromide, sertraline hydrochloride, and venlafaxine hydrochloride.
Main Outcome Measures Neonatal abstinence syndrome was assessed with the Finnegan score as follows: score of 8 or above, severe; score of 4 to 7, mild; and score of 0 to 3, normal. All infants were followed up with a standardized protocol that included repeated Finnegan score assessments and cardiorespiratory monitoring until normalization of the Finnegan score.
Results Of the 60 neonates exposed to SSRIs in utero, 8 showed severe and 10 showed mild symptoms of a neonatal abstinence syndrome. All nonexposed neonates had a normal Finnegan score. In neonates who developed severe symptoms, the maximum mean daily Finnegan scores were recorded within 2 days after birth, although maximum individual scores were recorded as long as 4 days after birth.
Conclusions Neonatal abstinence syndrome occurs in 30% of neonates exposed to SSRIs in utero. These neonates should be monitored for at least 48 hours after birth. The long-term effects of prolonged exposure to SSRIs, particularly in neonates who develop severe symptoms, have yet to be determined.
Author Affiliations: Neonatal Intensive Care Unit, Schneider Children's Medical Center of Israel, Petah Tiqwa (Drs Levinson-Castiel, Merlob, Linder, Sirota, and Klinger); Department of Neonatology, Rabin Medical Center, Petah Tiqwa (Drs Merlob, Linder, Sirota, and Klinger); and Sackler School of Medicine, Tel Aviv University, (Drs Merlob, Linder, Sirota, and Klinger), Tel Aviv, Israel.
RELATED LETTERS
Neonatal Adverse Reactions After In Utero Exposure to Selective Serotonin Reuptake Inhibitors: Still Controversial
Louise Beaulac-Baillargeon and Nina Boucher
Arch Pediatr Adolesc Med. 2006;160(8):855-856.
EXTRACT
| FULL TEXT
Neonatal Adverse Reactions After In Utero Exposure to Selective Serotonin Reuptake Inhibitors: Still Controversial—Reply
Gil Klinger, Rachel Levinson-Castiel, and Paul Merlob
Arch Pediatr Adolesc Med. 2006;160(8):856.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Poor Neonatal Adaptation After in Utero Exposure to Duloxetine
EYAL and YAEGER
Am. J. Psychiatry 2008;165:651-651.
FULL TEXT
Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study
Oberlander et al.
Br. J. Psychiatry 2008;192:338-343.
ABSTRACT
| FULL TEXT
Prescribing antidepressants to pregnant women: What is a family physician to do?
Einarson and Koren
cfp 2007;53:1412-1414.
FULL TEXT
Prescrire des antidepresseurs aux femmes enceintes: Que doivent faire les medecins de famille?
Einarson and Koren
cfp 2007;53:1423-1425.
FULL TEXT
First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
Louik et al.
NEJM 2007;356:2675-2683.
ABSTRACT
| FULL TEXT
Safety of selective serotonin reuptake inhibitors in pregnancy
Donnelly and Paton
Psychiatr. Bull. 2007;31:183-186.
ABSTRACT
| FULL TEXT
Potential Medical and Surgical Complications of Serotonergic Antidepressant Medications
Looper
Psychosomatics 2007;48:1-9.
ABSTRACT
| FULL TEXT
Effects of Selective Serotonin Reuptake Inhibitors and Venlafaxine During Pregnancy in Term and Preterm Neonates
Ferreira et al.
Pediatrics 2007;119:52-59.
ABSTRACT
| FULL TEXT
Neonatal Adverse Reactions After In Utero Exposure to Selective Serotonin Reuptake Inhibitors: Still Controversial--Reply
Klinger et al.
Arch Pediatr Adolesc Med 2006;160:856-856.
FULL TEXT
Neonatal Adverse Reactions After In Utero Exposure to Selective Serotonin Reuptake Inhibitors: Still Controversial
Beaulac-Baillargeon and Boucher
Arch Pediatr Adolesc Med 2006;160:855-856.
FULL TEXT
SSRI-Exposed Babies: Monitor Them for at Least 48 Hours
JWatch Psychiatry 2006;2006:10-10.
FULL TEXT
SSRI Withdrawal Syndrome in Term Newborns
Aldous
AAP Grand Rounds 2006;15:72-73.
FULL TEXT
JOURNAL WATCH PEDIATRICS & ADOLESCENT MEDICINE
Arch. Dis. Child. 2006;91:539-540.
FULL TEXT
Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn.
Reefhuis et al.
NEJM 2006;354:2188-2190.
FULL TEXT
SSRI-Exposed Babies: Monitor Them for at Least 48 Hours
JWatch Women's Health 2006;2006:7-7.
FULL TEXT
Is Prenatal SSRI Exposure Harmful to Newborns?
JWatch Pediatrics 2006;2006:1-1.
FULL TEXT
SSRI Exposure in Utero -- Harmful to Newborns
JWatch General 2006;2006:5-5.
FULL TEXT
|
